COVID-19 and medical litigation: More than just the obvious.


Journal

Emergency medicine Australasia : EMA
ISSN: 1742-6723
Titre abrégé: Emerg Med Australas
Pays: Australia
ID NLM: 101199824

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 04 05 2020
accepted: 05 05 2020
pubmed: 10 5 2020
medline: 6 8 2020
entrez: 10 5 2020
Statut: ppublish

Résumé

COVID-19 has massively changed the health landscape around the world. Wide-ranging changes to healthcare delivery have occurred, especially in hospitals and EDs. Health services have made local decisions about care pathways, in some cases deviating from what would, until recently, have been considered widely accepted care. These changes bring with them new medicolegal risk for clinicians. In Australia, civil liability Acts provide protection for professionals when the criterion of having undertaken 'competent' practice that would be 'widely accepted' 'in the circumstances' is met. There is doubt how courts, and the medical experts who advise them, will evaluate clinical care provided during the pandemic when health services have developed local care pathways and there is no nationally accepted standard.

Identifiants

pubmed: 32386246
doi: 10.1111/1742-6723.13548
pmc: PMC7272927
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

703-705

Informations de copyright

© 2020 Australasian College for Emergency Medicine.

Références

Cochrane Database Syst Rev. 2017 Jul 13;7:CD004104
pubmed: 28702957
Cochrane Database Syst Rev. 2019 Apr 05;4:CD005351
pubmed: 30950507

Auteurs

Anne-Maree Kelly (AM)

Joseph Epstein Centre for Emergency Medicine Research, Western Health, Melbourne, Victoria, Australia.
Department of Medicine, Melbourne Medical School - Western Precinct, The University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH